ZTS Zoetis Inc

Price (delayed)

$172.79

Market cap

$78.84B

P/E Ratio

33.29

Dividend/share

$1.61

EPS

$5.19

Enterprise value

$83.64B

Zoetis Inc. is the world's largest producer of medicine and vaccinations for pets and livestock. The company was a subsidiary of Pfizer, the world's largest drug maker, but with Pfizer's ...

Highlights
The P/E is 18% lower than the 5-year quarterly average of 40.7 and 7% lower than the last 4 quarters average of 35.7
Zoetis's EPS has increased by 17% YoY and by 2.2% QoQ
Zoetis's quick ratio has decreased by 3.4% QoQ

Key stats

What are the main financial stats of ZTS
Market
Shares outstanding
456.3M
Market cap
$78.84B
Enterprise value
$83.64B
Valuations
Price to book (P/B)
15.64
Price to sales (P/S)
9.06
EV/EBIT
25.95
EV/EBITDA
22.48
EV/Sales
9.58
Earnings
Revenue
$8.73B
EBIT
$3.22B
EBITDA
$3.72B
Free cash flow
$1.75B
Per share
EPS
$5.19
Free cash flow per share
$3.83
Book value per share
$11.05
Revenue per share
$19.07
TBVPS
$22.48
Balance sheet
Total assets
$14.35B
Total liabilities
$9.3B
Debt
$6.77B
Equity
$5.06B
Working capital
$4.45B
Liquidity
Debt to equity
1.34
Current ratio
3.33
Quick ratio
1.71
Net debt/EBITDA
1.29
Margins
EBITDA margin
42.6%
Gross margin
70%
Net margin
27.4%
Operating margin
36.9%
Efficiency
Return on assets
16.9%
Return on equity
48.4%
Return on invested capital
24.5%
Return on capital employed
25.9%
Return on sales
36.9%
Dividend
Dividend yield
0.93%
DPS
$1.61
Payout ratio
31.1%

ZTS stock price

How has the Zoetis stock price performed over time
Intraday
-0.92%
1 week
2.32%
1 month
17.95%
1 year
-3.76%
YTD
-12.45%
QTD
2.12%

Financial performance

How have Zoetis's revenue and profit performed over time
Revenue
$8.73B
Gross profit
$6.12B
Operating income
$3.22B
Net income
$2.39B
Gross margin
70%
Net margin
27.4%
The net income has grown by 15% YoY and by 2% from the previous quarter
Zoetis's operating income has increased by 13% YoY
The gross profit has grown by 9% YoY and by 2.3% from the previous quarter
ZTS's revenue is up by 8% YoY and by 2.2% QoQ

Growth

What is Zoetis's growth rate over time

Valuation

What is Zoetis stock price valuation
P/E
33.29
P/B
15.64
P/S
9.06
EV/EBIT
25.95
EV/EBITDA
22.48
EV/Sales
9.58
The P/E is 18% lower than the 5-year quarterly average of 40.7 and 7% lower than the last 4 quarters average of 35.7
Zoetis's EPS has increased by 17% YoY and by 2.2% QoQ
The stock's price to book (P/B) is 19% less than its 5-year quarterly average of 19.4 and 6% less than its last 4 quarters average of 16.6
ZTS's equity is up by 13% year-on-year
ZTS's price to sales (P/S) is 13% lower than its 5-year quarterly average of 10.4 and 7% lower than its last 4 quarters average of 9.7
ZTS's revenue is up by 8% YoY and by 2.2% QoQ

Efficiency

How efficient is Zoetis business performance
ZTS's return on assets is up by 14% year-on-year
The company's return on equity rose by 6% YoY
Zoetis's return on sales has increased by 4.5% YoY

Dividends

What is ZTS's dividend history
DPS
$1.61
Dividend yield
0.93%
Payout ratio
31.1%
Recent dividends

Financial health

How did Zoetis financials performed over time
ZTS's total assets is 54% greater than its total liabilities
ZTS's total assets is up by 4.3% year-on-year
Zoetis's quick ratio has decreased by 3.4% QoQ
The debt is 34% higher than the equity
ZTS's equity is up by 13% year-on-year
Zoetis's debt to equity has decreased by 11% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.